EU Commission approved Roche’s Tecentriq in combination with Avastin for the treatment of people with liver cancer
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in ...
